Trial intelligence / Profile preview

WASPE Sleep Adjustment for Pediatric Radiotherapy

NCT06443632Completed

Sponsor
Shandong Cancer Hospital
Start
Jun 2024
Primary completion
Jun 2025
Countries
1
01

Overview

Randomised, open-label trial in pediatric cancer (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoint: Per-fraction radiotherapy completion without pharmacologic sedation. Started Jun 2024; status: completed.

02

Conditions

pediatric cancer

Beyond the preview

Go deeper on NCT06443632.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06443632.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call